PRospective phenotypIng and Multi-omic Endotyping of Progressive Pulmonary Fibrosis
Part of paid clinical trials in Worcester, Massachusetts.
- Sponsor
- University of Massachusetts, Worcester
- Study ID
- NCT06855329
- Status
- Recruiting
Conditions
- Interstitial Lung Disease
- Progressive Pulmonary Fibrosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Study Details
This is a prospective, observational cohort study. Participants with non-idiopatic pulmonary fibrosis, interstitial lung disease (ILD) will be followed for 24 months to systematically collect clinical, imaging, and biospecimen data. The primary objective is to optimize progressive pulmonary fibrosis (PPF) classification and establish PPF incidence for key ILD subtypes. Additional exploratory objectives are to 1) Prospectively validate a novel PPF classifier and assess performance durability over time, and 2) Determine whether multi-dimensional PPF prediction outperforms component approaches.
Key Dates
- Start date
- May 1, 2025
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2029
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 500 participants (estimated)
Primary Outcome Measure
Transplant-free survival (TFS) [ Time Frame: 12-months to 24-months (following an observation period from 0 months to 12 months) ]
Central Contacts
- Fernando J Martinez, MD, MS508-334-8685
- Elizabeth Peters, BSN774-455-4432
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Massachusetts Chan Medical School | Worcester | Massachusetts | 01655 | Roberto Caricchio, MD |
| University of Michigan | Ann Arbor | Michigan | 48109 | Janelle Pugashetti, MD Nisha Mohan |
| University of Texas Southwestern | Dallas | Texas | 75390 | |
| University of Virginia | Charlottesville | Virginia | 22908 | Yousef Althulth |
| University of Washington | Seattle | Washington | 98195 |
Find similar trials in Worcester, MA
Related Studies
- Bio-Banking of Specimens for Advanced Lung Disease and Lung Transplant ResearchRecruiting · Baylor Research Institute · Dallas, Texas
- University of Virginia Natural History StudyEnrolling By Invitation · University of Virginia · Charlottesville, Virginia
- Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseasePHASE3 · Enrolling By Invitation · United Therapeutics · Birmingham, Alabama
- Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung DiseasePHASE2 · Recruiting · Children's Hospital Medical Center, Cincinnati · San Francisco, California